CQAM 2026
October 28 @ 8:00 am – October 30 @ 5:00 pm
7e Congrès québécois sur la maladie d’Alzheimer et les maladies apparentées
Discover how the NULISA™ Platform and ARGO™ HT System are transforming research in CNS diseases and beyond. The NULISA™ Platform delivers ultra-high sensitivity, broad dynamic range, and high multiplexing capabilities for precise biomarker detection and quantitation. Paired with the ARGO™HT System—a fully automated, high-throughput platform capable of generating single-plex results in under 8 hours and multiplex results in under 15 hours.